3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Cardiovascular Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pencina, M; Sniderman, AD; Thanassoulis, G | 1 |
| Jain, P; Jones, ML; Prakash, S; Saha, S; Shah, D; Tomaro-Duchesneau, C | 1 |
| Devi, J; Ganesh, S; Kumar, S; Rajkumar, J; Ravindran, R; Roy, S; Sharma, N; Thakur, AR | 1 |
| Ande, SR; Chen, QM; Hashemi, M; Hoshyar, R; Naderi, M; Solomon, C; Zuse, A | 1 |
| Chandra, R; Rai, SK; Sharma, M; Tiwari, M; Tiwari, RK | 1 |
| Morrison, DC; Papasian, CJ; Qureshi, AA; Qureshi, N; Reis, JC | 1 |
| Giampietro, O; Matteucci, E | 1 |
2 review(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Cardiovascular Diseases
| Article | Year |
|---|---|
Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Topics: Acyl Coenzyme A; Animals; Cardiovascular Diseases; Cholesterol; GTP Phosphohydrolases; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infections; Mevalonic Acid; Neoplasms; Polyisoprenyl Phosphates; Sesquiterpenes; Signal Transduction | 2017 |
Statin intolerance: why and what to do - with a focus on diabetic people.
Topics: Acyl Coenzyme A; Animals; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Risk Factors; Signal Transduction | 2013 |
5 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Cardiovascular Diseases
| Article | Year |
|---|---|
ApoB.
Topics: Acyl Coenzyme A; Apolipoprotein B-100; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Chylomicrons; Evidence-Based Medicine; Humans; Lipoproteins, VLDL; Molecular Mimicry; Predictive Value of Tests; Risk Assessment; Risk Factors; Triglycerides | 2019 |
Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation.
Topics: Acyl Coenzyme A; Amidohydrolases; Cardiovascular Diseases; Cholesterol; Culture Media; Humans; In Vitro Techniques; Lactobacillus plantarum; Probiotics | 2014 |
Interaction Studies of Withania Somnifera's Key Metabolite Withaferin A with Different Receptors Assoociated with Cardiovascular Disease.
Topics: Acyl Coenzyme A; C-Reactive Protein; Cardiovascular Diseases; Ligands; Molecular Docking Simulation; Receptors, Adrenergic, beta-1; Receptors, Estrogen; Withania; Withanolides; Xanthine Dehydrogenase | 2015 |
Effects of nitric oxide modulators on cardiovascular risk factors in mild hyperhomocysteinaemic rat model.
Topics: Acyl Coenzyme A; Animals; Aorta, Thoracic; C-Reactive Protein; Cardiovascular Diseases; Caveolin 2; Disease Models, Animal; Hyperhomocysteinemia; Leukotrienes; Lipid Metabolism; Liver; Male; Methionine; Nitric Oxide; Nitric Oxide Donors; Nitroarginine; Nitroprusside; Oxidative Stress; Rats; Rats, Wistar; Receptors, Purinergic P2; Resistin; Risk Factors | 2008 |
Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice.
Topics: Acyl Coenzyme A; Adrenal Cortex Hormones; Animals; Cardiovascular Diseases; Cell Line; Cytokines; Dietary Supplements; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Muscles; Oxidoreductases; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rabbits; Tocotrienols | 2010 |